Devicemaker Stryker has acquired Stanmore Implants in an all-cash transaction for $52 million.
Stanmore focuses on providing supplies for surgeons who treat orthopedic oncology.
With the acquisition, Stryker has added to its extensive portfolio of patient-specific and off-the-shelf implant systems aimed at limb salvage. The move also expands its presence in the global orthopedic oncology market. — Joya Patel